AGP Executive Report
Last update: 2 hours agoMedicare Coverage: New 2027 ratings bring a mixed picture ahead of U.S. open enrollment on Oct. 15: Humana says 95% of its Medicare Advantage members are in plans rated four stars or higher, while other reports warn that seniors will have fewer top-rated options. Medicaid Changes: U.S. coverage changes could leave 10 million more people uninsured by 2034, according to a Congressional Budget Office estimate; Louisiana, meanwhile, won approval to provide Medicaid services during the 60 days before some incarcerated people are released. Drug Costs and Marketing: India plans tighter controls on prescription-drug advertising and a 30% trade-margin cap on many cancer medicines, which could cut some prices by up to 70%. Separately, a review of more than 93 studies found that drug-company gifts and payments were linked to prescribing promoted drugs, including potentially inappropriate prescriptions. Treatment Access: A real-world study reports positive Dupixent results for children with atopic dermatitis across skin colors, addressing a gap in representation in clinical research.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
